Climate Change Data

Shanghai Henlius Biotech, Inc.

Climate Impact & Sustainability Data (2022, 2023)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:21,163.93 tCO2e/year
Scope 1 Emissions:6,480.15 tCO2e/year
Scope 2 Emissions:14,683.78 tCO2e/year
Total Energy Consumption:206,789.02 GJ/year
Water Consumption:236,195 m3/year
Waste Generated:855.27 tons/year
Carbon Intensity:0.07 tCO2e per 10,000CNY

ESG Focus Areas

  • Product quality and safety
  • Product innovation and R&D
  • Employee rights protection
  • Intellectual property management
  • Corporate governance

Environmental Achievements

  • Invested approximately RMB7.575 million in environmental protection.
  • Reduced the volume of wastewater discharge by 9,724 tons with the help of the reclaimed water reuse system.
  • Songjiang facility and the Xuhui facility reused 22,051 and 6,635 cubic metres of reclaimed water respectively.

Social Achievements

  • Launched the “H - Lifelong Wellbeing Program”, a Patient Assistance Program (PAP), donating 57,200 units of HANSIZHUANG valued at about 320 million.
  • Successfully launched 5 products in China and 1 product in global market, benefiting 350,000+ patients.
  • Achieved 100% coverage of occupational health examinations with no cases of occupational diseases and no working days lost due to work-related injuries.

Governance Achievements

  • Established a three-tier ESG governance structure—the Company's board of directors, the ESG committee, the ESG leading group, and the working group.
  • Obtained ISO/IEC 27001:2013 information security management system certification.
  • Completed 51 departmental compliance training sessions with a total of 4,639 attendees.

Climate Goals & Targets

Environmental Challenges

  • Supply chain disruptions due to Covid-19 pandemic and extreme weather events.
  • Climate change risks (physical and transition risks).
Mitigation Strategies
  • Implemented contingency plans to address extreme weather events and supply chain disruptions.
  • Developed alternative sourcing strategies.
  • Implemented energy efficiency projects and optimized measures in process optimization, technology upgrades and resource reuse.

Supply Chain Management

Responsible Procurement
  • Supplier Code of Conduct
  • Supplier Management Regulations
  • Direct Procurement Supplier Management Process
  • Direct Procurement Management System
  • Green Supply Chain Proposal

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events
  • Average temperature rise
Transition Risks
  • Technology risk
  • Policy and legal risk
  • Market risk
  • Reputational risk
Opportunities
  • Use recycling technologies
  • Technology transformation
  • New technology application
  • New energy procurement
  • Low-emission energy sources
  • Responsible supply chain
  • Environment-friendly products

Reporting Standards

Frameworks Used: GRI Standards, AA1000 series of standards

Certifications: China GMP, EU GMP, ISO/IEC 27001:2013

Third-party Assurance: SGS

Awards & Recognition

  • Best Companies to Work for in Asia 2022

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:21,973 tCO2e/year
Scope 1 Emissions:6,908.63 tCO2e/year
Scope 2 Emissions:15,064.37 tCO2e/year
Total Energy Consumption:26,414,814 kWh/year (purchased power), 3,183,287 cubic meters/year (natural gas), 11,680.58 liters/year (gasoline)
Water Consumption:259,437 m3/year
Waste Generated:642.66 tons/year (total solid waste)
Carbon Intensity:0.46 tCO2e/liter (2023)

ESG Focus Areas

  • Product quality and safety
  • Emissions management
  • Product innovation and R&D
  • Employee rights protection
  • Anti-corruption and business ethics
  • Intellectual property rights management
  • Corporate governance
  • Customer rights and privacy protection

Environmental Achievements

  • Invested approximately RMB 6.2421 million in environmental protection.
  • Recycled water: 5,714,905.8 cubic meters.
  • Reduced energy consumption per RMB 10,000 output value of Xuhui Facility by about 46% by the end of December 2023.
  • Annual fuel saving of 2,160.61 liters compared with the standard fuel consumption of the vehicles.
  • Reclaimed water reuse volume in Xuhui Facility and Songjiang First Plant were 7,802.8 tons and 3,305 tons respectively.

Social Achievements

  • Launched Patient Assistance Program (PAP), providing HANSIZHUANG for free.
  • HANSIZHUANG included into Huiminbao catalog in 80 cities.
  • Continued “To the Time, to Life” cancer patient care program and “Rural Medical Care Public Welfare Activity”, benefiting over 4,700 patients and 2,200 HCPs.
  • Total training hours reaching 179,509.53 hours with 161 hours per capita.
  • Employee engagement increased by 0.3 points compared to last year.

Governance Achievements

  • Conducted 2 ESG-specific meetings and 1 anti-corruption compliance training session for 100% of Board members.
  • Conducted 101 anti-corruption compliance training sessions for employees.
  • More than 1,500 employees participated in “Align with Heart, Govern with Action” in the 2023 Henlius Compliance Day.
  • Successfully passed a review of ISO/IEC 27001: 2013 information security management system certification.
  • Applied for 2 patents.

Climate Goals & Targets

Short-term Goals:
  • By 2025, reduce carbon emission intensity by 15% compared with the base year of 2021 (taking commercial production capacity as the unit).
  • By 2025, reduce water intensity by 8% compared with the base year of 2021 (taking commercial production capacity as the unit).
  • By 2025, reduce energy consumption intensity by 15% compared with the base year of 2021 (taking commercial production capacity as the unit).
  • By 2025, 100% of hazardous waste will be disposed in compliance with regulations, and our emission intensity of solid waste will be reduced by 10% (taking commercial production capacity as the unit).

Environmental Challenges

  • Extreme weather events interrupting production and operation.
  • Average temperature rise increasing operating costs.
  • Adoption of new technologies increasing upfront operating costs.
  • Evolving laws and regulations.
  • Stakeholder concerns about climate change.
  • Market expectations regarding carbon-neutral strategies.
Mitigation Strategies
  • Developed plans for flood prevention and emergency response.
  • Implemented climate risk management measures.
  • Optimized wastewater management process and treatment technology.
  • Updated pollutant emission systems and strengthened the management of unorganized emissions of exhaust gas.
  • Improved the Management System for Air Pollution Prevention and Control.
  • Established supply chain Business Continuity Management (BCM).

Supply Chain Management

Supplier Audits: All Class A material suppliers accept on-site quality audits. Due diligence completed on 123 suppliers.

Responsible Procurement
  • Supplier Code of Conduct
  • Supplier Management Regulations
  • Direct Procurement Supplier Management Process
  • Direct Procurement Management System
  • General Outline of Indirect Procurement Management System
  • Green Supply Chain Proposal

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events
  • Average temperature rise
Transition Risks
  • Technology risks
  • Policy and regulation risks
  • Reputation risks
  • Market risks
Opportunities
  • Recycling technologies
  • Technology transformation
  • More efficient production process
  • New technology application
  • New energy procurement
  • Low-emission energy sources
  • Responsible supply chain
  • Environment-friendly products

Reporting Standards

Frameworks Used: GRI Standards, AA1000 series of standards

Certifications: ISO/IEC 27001:2013

Third-party Assurance: SGS

Awards & Recognition

  • 2022 Wind ESG Hong Kong Stock Best Practice Award
  • 2022 Top 10 Innovative Pharmaceutical Enterprises
  • 2022 Outstanding Scientific Innovative Enterprise Award
  • 2022 Top Quality Development Achievement Enterprises in Chinese Pharmaceutical Industry
  • 2022 China Pharmaceutical Social Responsibility Media Watch - Public Welfare Pillar
  • 2022 Shanghai New Excellent Medical Device Product Catalog
  • 2022 BioCon Awards - Biopharmaceutical Enterprise Star
  • 2023 Top 10 Most Influential Antibody Company
  • 2023 Best Companies to Work For in Asia
  • 2023 Shanghai Key Industries International Competitiveness Excellence Cases
  • 2023 Changchun Annual Innovative Pharmaceutical Enterprises Award
  • 2023 Huaxia Health ESG Outstanding Enterprises
  • 2023 13th China Listed Company Reputation Ranking “Biopharmaceutical Company with the Most Growth”
  • 2023 Shanghai Drug Manufacturer Credit Assessment Grade A
  • 2023 Bloomberg Businessweek (Chinese Edition) Golden Stock Best ESG Disclosure Award
  • 2023 Outstanding Public Welfare Project Award
  • 2023 High-Quality Development Enterprises in the Healthcare Industry
  • 2023 CLS·ESG ZhiYuan Award – Social (S) Pioneer Enterprise Award
  • The 11th Best Public Relations Case Awards